NCT05979207 - Phase 1b MMV367 PK/PD and Safety in Healthy Adult Volunteers Experimentally Infected With Blood Stage P. Falciparum | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

August 1, 2023

Primary Completion Date

October 30, 2023

Study Completion Date

October 30, 2023

Conditions

InfectionsVector Borne DiseasesSystemic Inflammatory Response SyndromeInflammationPathologic ProcessesMalariaMalaria,FalciparumParasitemiaParasitic DiseasesProtozoan InfectionsAntimalarialsAnti-Infective Agents

Interventions

DRUG

MMV367

Single dose

OTHER

P. falciparum IBSM infection

Induced Blood Stage Malaria

Trial Locations (2)

4101

South Bank, Brisbane

4506

USC Clinical Trials, Morayfield, Brisbane